DENTSPLY SIRONA Inc. (FRA:DY2)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.73B -41.2% |
| Revenue (ttm) | 3.19B -1.0% |
| Net Income | -544.66M |
| EPS | -2.73 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 6.79 |
| Dividend | 0.41 (4.63%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 35 |
| Open | 8.40 |
| Previous Close | 8.44 |
| Day's Range | 8.40 - 8.62 |
| 52-Week Range | 8.18 - 14.38 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 5, 2026 |
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as w... [Read more]
Financial Performance
In 2025, DENTSPLY SIRONA's revenue was $3.68 billion, a decrease of -2.98% compared to the previous year's $3.79 billion. Losses were -$598.00 million, -34.29% less than in 2024.
Financial numbers in USD Financial StatementsNews
DENTSPLY SIRONA Transcript: AGM 2026
The meeting, held virtually, covered four proposals including board elections, auditor ratification, executive compensation, and an incentive plan amendment. All proposals passed by majority vote, with no questions submitted by stockholders.
DENTSPLY SIRONA Transcript: Stifel Jaws & Paws Conference 2026
Leadership is driving organizational simplification, digital transformation, and expanded distribution, with restructuring savings reinvested in education, R&D, and commercial support. Sequential revenue improvement is targeted by late 2026, with division-specific strategies to regain share and drive growth through 2028.
Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets
CHARLOTTE, N.C., May 26, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the str...
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference
CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & P...
Dentsply Sirona price target lowered to $17 from $18 at UBS
UBS lowered the firm’s price target on Dentsply Sirona (XRAY) to $17 from $18 and keeps a Buy rating on the shares.
Dentsply Sirona price target lowered to $14 from $16 at Mizuho
Mizuho lowered the firm’s price target on Dentsply Sirona (XRAY) to $14 from $16 and keeps a Neutral rating on the shares.
DENTSPLY SIRONA Earnings Call Transcript: Q1 2026
Q1 2026 results were in line with expectations, with revenue stable and early progress on cost savings and innovation. The company maintained its full-year outlook, focusing on restructuring, debt reduction, and new product launches, while monitoring macro risks and competitive pressures.
DENTSPLY SIRONA Earnings release: Q1 2026
DENTSPLY SIRONA released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
DENTSPLY SIRONA Slides: Q1 2026
DENTSPLY SIRONA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
DENTSPLY SIRONA Quarterly report: Q1 2026
DENTSPLY SIRONA has published its Q1 2026 quarterly earnings report on May 5, 2026.
Dentsply Sirona Reports First Quarter 2026 Results
News Summary Reported net sales of $880 million Delivered GAAP gross margin of 48.5% , GAAP net loss per share of ($0.05) Achieved adjusted gross margin of 50.7% , adjusted EBITDA margin of 14.7% , ad...
Dentsply Sirona signs distribution agreement with Atlanta Dental Supply
Dentsply Sirona (XRAY) announced an enhanced distribution agreement with Atlanta Dental Supply, under which Atlanta Dental will begin offering Dentsply Sirona’s connected technology solutions portfoli...
Dentsply Sirona Expands U.S. Distribution Footprint Through Enhanced Agreement with Atlanta Dental Supply
CHARLOTTE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced an enha...
DENTSPLY SIRONA Proxy statement: Proxy filing
DENTSPLY SIRONA filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
DENTSPLY SIRONA Proxy statement: Proxy filing
DENTSPLY SIRONA filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5
CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and ...
Dentsply Sirona initiated with a Sell at Citi
Citi initiated coverage of Dentsply Sirona (XRAY) with a Sell rating and $10 price target The firm launched the animal health and dental sectors with a “cautiously optimistic” view. Citi…
Dentsply Sirona price target lowered to $13 from $15 at Evercore ISI
Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Dentsply Sirona (XRAY) to $13 from $15 and keeps an In Line rating on the shares. The firm made…
DENTSPLY SIRONA Transcript: Leerink Global Healthcare Conference 2026
Leadership is driving a turnaround with urgent execution, strategic R&D focus, and simplified dealer partnerships. Investments in clinical education, AI, and product modernization are expected to yield results in the second half, with EMEA and Asia Pacific as key growth regions.
Dentsply Sirona, Siemens Healthineers share findings from trial of MRI system
Dentsply Sirona (XRAY) and Siemens Healthineers (SMMNY) share key findings from the clinical trial for validation of their dental-dedicated MRI system. In addition to confirming its significant potent...
First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics
Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI 1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United...
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026
CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners G...
Dentsply Sirona price target raised to $18 from $16 at UBS
UBS analyst Kevin Caliendo raised the firm’s price target on Dentsply Sirona (XRAY) to $18 from $16 and keeps a Buy rating on the shares.
Dentsply Sirona price target raised to $17 from $14 at Barrington
Barrington raised the firm’s price target on Dentsply Sirona (XRAY) to $17 from $14 and keeps an Outperform rating on the shares post the Q4 report. The firm sees some…
Dentsply Sirona price target raised to $16 from $14 at Mizuho
Mizuho analyst Steven Valiquette raised the firm’s price target on Dentsply Sirona (XRAY) to $16 from $14 and keeps a Neutral rating on the shares. The firm updated the company’s…